Delivery Order SPE2DB22D1202-SPE2DB24FUTS0

Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $9.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,980,482 units of 8 mg Ondansetron hydrochloride tablets. The contract has a ceiling value of $1,664.08 and a performance period through March 18, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,678,777 units of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $5,996.20 and an ultimate completion date of September 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of 4,563,925,268 units of Ondansetron ODT 4 mg tablets in 30-count packages, with a ceiling value of $8,952.84 and a period of performance through March 12, 2024. This delivery order falls under an...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4,563,956,711 units of Ondansetron ODT 8 mg Tablets in 30-count packages. The total ceiling value of the order is $3,251.93 and the period of performance runs through March 14, 2024. Amerisourcebergen Drug Corp, through its Corporate Office in Conshohocken, Pennsylvania, is the prime contractor....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,286,529 units of Ondansetron ODT 4 mg tablets, a prescription medication. The contract has a ceiling value of $3,530.53 and a completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,503,677 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price contract has a ceiling value of $22,938.12 and an ultimate completion date of November 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,563,881,866 units of the pharmaceutical product Ondansetron HCL 4 mg tablets. The total potential value of the award is $45,461.22, with a completion date of March 7, 2024. This delivery order is part of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,222.90 delivery order is for the supply of 4,563,969,438 units of Ondansetron ODT 8 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,971,705 units of Ondansetron ODT 4 mg tablets in 30-count packages, with a ceiling value of $9,616.25. The award has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,255.99, is for the supply of 4,562,925,716 units of Ondansetron HCL 8 mg tablets. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUTS0
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,563,957,267 units of Ondansetron HCL 8 MG Tablets in 30-count packages. The award has a ceiling value of $9,382.40 and a period of performance through March 14, 2024.

Amerisourcebergen Drug Corp is the prime contractor on this order, which is issued under a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designations.

Generated 6/12/24, 10:21 AM